[The use of laferon in acute respiratory viral infections].
Therapeutical efficacy of laferon (J2-interferon) was in children of preschool and school ages with acute respiratory viral infections. Endonasal employment of the drug during 3 days of acute period of the illness significantly decreases the duration of the period of catarrh and intoxication, being accompanied by positive immunological reactions on the part of T-cellular immunity and immunoglobulin synthesis.
Kazakova
L N
LN
D000208:Acute Disease; D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004341:Drug Evaluation; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012141:Respiratory Tract Infections / Q000276:immunology / Q000628:therapy*; D014777:Virus Diseases / Q000276:immunology / Q000628:therapy*
D000998:Antiviral Agents; D007370:Interferon Type I; D011994:Recombinant Proteins
Primenenie laferona pri ostrykh respiratornykh virusnykh infektsiiakh.